MarketInOut Stock Screener Log In | Sign Up
 

Morepen Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 06/12/2026
Morepen Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization27,052 mln
Float310 mln
Earnings Date08/06/2026

EPS

1.79
Moderate

P / E

28.02
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.05
Caution advised

Relative Strength

95 / 100
Top performer

Debt / Equity

0.17
Very low leverage

Business Description

Morepen Laboratories Limited is an India-based pharmaceutical company founded in 1984 that produces and sells drug ingredients, prescription and generic medicines, and consumer health products across India, the United States, and other global markets. Its product range covers treatments for conditions such as diabetes, high blood pressure, allergies, and digestive issues, alongside a broad line of home health devices including blood pressure monitors, glucose meters, and nebulizers. The company also sells everyday healthcare items under its Dr. Morepen brand, including products for fever, pain relief, and minor burns.

Key Fundamentals

EPS1.79
P/E28.02
ROE7.91
RPS32.88
ROIC5.07
ROA5.22
Interest Cover5.43
EBITDA, mln1,728
EV / EBITDA12.78
EV / EBIT17.12
Revenue, mln18,057
EV / Revenue1.34

Financial Strength

Altman Z-Score4.35
Piotroski F-Score 4 / 9
Beneish M-Score-2.05
Price to Lynch Fair Value6.29
Price to Graham Number2.04
Shiller PE Ratio30.73

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.55% 97 / 100   
1 Month 14.39% 89 / 100   
2 Months 14.55% 76 / 100   
6 Months 15.42% 82 / 100   
1 Year -21.02% 39 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us